Importantly, a growing number of studies have shown that IKBIP may serve as a predictive biomarker and a potential therapeutic target for several cancers, such as glioblastoma [13], renal cancer [14] and lung cancer [15]. This evidence concerns the gene IKBIP and glioblastoma.